These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
||||||||||
|
|
|
||||||||||
|
|
|
|
|||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||
|
|
|
|
||||||
|
|
x | Accelerated filer | o | ||||||||
| Non-accelerated filer |
o
|
Smaller reporting company
|
|
||||||||
| Emerging growth company |
|
||||||||||
| TABLE OF CONTENTS | ||||||||
|
Form 10-Q
Cross Reference
|
Page
|
|||||||
| Part I, Item 1. | ||||||||
| Part I, Item 2. | ||||||||
| Part I, Item 3. | ||||||||
| Part I, Item 4. | ||||||||
| Part II, Item 1. | ||||||||
|
Risk Factors
|
Part II, Item 1A. | |||||||
| Part II, Item 2. | ||||||||
| Part II, Item 3. | ||||||||
| Part II, Item 4. | ||||||||
| Part II, Item 5. | ||||||||
| Part II, Item 6. | ||||||||
| TRINET |
2
|
2023 Q1 FORM 10-Q | ||||||
| GLOSSARY | |||||
| TRINET |
3
|
2023 Q1 FORM 10-Q | ||||||
| GLOSSARY | |||||
| 2021 Credits | Our announced 2021 credits, which provided eligible clients with discretionary credits, subject to certain predefined conditions. | ||||
| 2022 Credits | Includes both of our announced 2022 credits, each of which provides eligible clients with discretionary credits, subject to certain predefined conditions. | ||||
| 2021 Credit Agreement |
Our credit agreement dated February 26, 2021
|
||||
| 2021 Revolver |
Our $500 million revolving line of credit included in our 2021 Credit Agreement
|
||||
| 2029 Notes | Our $500 million senior unsecured notes maturing in March 2029 | ||||
| AFS | Available-for-sale | ||||
| CARES Act | Coronavirus Aid Relief and Economic Security Act | ||||
| CEO | Chief Executive Officer | ||||
| CFO | Chief Financial Officer | ||||
| Clarus R+D | Clarus R+D Solutions, LLC | ||||
| COBRA | Consolidated Omnibus Budget Reconciliation Act | ||||
| Colleague | TriNet’s internal employees (as distinguished from WSEs and HRIS Users) | ||||
| COPS | Cost of providing services | ||||
| COVID-19 | Novel coronavirus | ||||
| D&A | Depreciation and amortization expenses | ||||
| EBITDA | Earnings before interest expense, taxes, depreciation and amortization of intangible assets | ||||
| EPS | Earnings Per Share | ||||
| ERISA | Employee Retirement Income Security Act | ||||
| ESAC | Employer Services Assurance Corporation | ||||
| ETR | Effective tax rate | ||||
| FFCRA | Families First Coronavirus Response Act | ||||
| G&A | General and administrative | ||||
| GAAP | Generally Accepted Accounting Principles in the United States | ||||
| HCM | Human capital management | ||||
| HR | Human Resources | ||||
| HRIS | Human resources information system | ||||
| HRIS User | A client employee who is not co-employed by a TriNet PEO (for example, employees of a TriNet Zenefits client) | ||||
| IRS | Internal Revenue Service | ||||
| ICR | Insurance cost ratio | ||||
| ISR | Insurance service revenues | ||||
| LIBOR | London Inter-bank Offered Rate | ||||
| MD&A | Management's Discussion and Analysis of Financial Condition and Results of Operations | ||||
| OE | Operating expenses | ||||
| PEO | Professional Employer Organization | ||||
| PFC | Payroll funds collected | ||||
| PPP | Paycheck Protection Program, a loan program administered by the U.S. Small Business Administration | ||||
| PSR | Professional service revenues | ||||
| R+D | Research and Development | ||||
| Recovery Credit |
Our 2020 Recovery Credit to provide eligible clients with one-time reductions against fees for future services
|
||||
| Recovery Credits | Collectively, our Recovery Credit, 2021 Credits, and 2022 Credits | ||||
| Reg FD | Regulation Fair Disclosure | ||||
| ROU | Right-of-use | ||||
| RSA | Restricted Stock Award | ||||
| RSU | Restricted Stock Unit | ||||
| SBC | Stock Based Compensation | ||||
| S&M | Sales and marketing | ||||
| S&P | Standard & Poor's | ||||
| TRINET |
4
|
2023 Q1 FORM 10-Q | ||||||
| GLOSSARY | |||||
| SD&P | Systems development and programming | ||||
| SEC | U.S. Securities and Exchange Commission | ||||
| SMB | Small and medium-size business | ||||
| U.S. | United States | ||||
| WSE | A worksite employee who is co-employed by a TriNet PEO | ||||
| YTD | Year to date | ||||
| Zenefits | YourPeople, Inc. (dba Zenefits) and its subsidiaries | ||||
| TRINET |
5
|
2023 Q1 FORM 10-Q | ||||||
| FORWARD LOOKING STATEMENTS AND OTHER FINANCIAL INFORMATION | |||||
| TRINET |
6
|
2023 Q1 FORM 10-Q | ||||||
| FORWARD LOOKING STATEMENTS AND OTHER FINANCIAL INFORMATION | |||||
| TRINET |
7
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| TRINET |
8
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| $1.2B | $169M | 82% | ||||||||||||||||||||||||
| Total revenues | Operating income | Insurance cost ratio | ||||||||||||||||||||||||
| 2 | % | increase | (17) | % | decrease | 2 | % | increase | ||||||||||||||||||
| $131M | $2.17 | $150M | ||||||||||||||||||||||||
| Net income | Diluted EPS | Adjusted Net income * | ||||||||||||||||||||||||
| (10) | % | decrease | (2) | % | decrease | (11) | % | decrease | ||||||||||||||||||
| 327,107 | 328,299 | 231,347 | ||||||||||||||||||||||||
| Average WSEs | Total WSEs | Average HRIS Users | ||||||||||||||||||||||||
| (5) | % | decrease | (6) | % | decrease | (9) | % | decrease | ||||||||||||||||||
| * | ||||||||||||||||||||||||||
| TRINET |
9
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| Three Months Ended March 31, | |||||||||||
| (in millions, except operating metrics data) | 2023 | 2022 | % Change | ||||||||
| Income Statement Data: | |||||||||||
| Professional service revenues | $ | 205 | $ | 194 | 6 | % | |||||
| Insurance service revenues | 1,041 | 1,024 | 2 | ||||||||
| Total revenues | 1,246 | 1,218 | 2 | ||||||||
| Insurance costs | 852 | 823 | 4 | ||||||||
| Operating expenses | 225 | 191 | 18 | ||||||||
| Total costs and operating expenses | 1,077 | 1,014 | 6 | ||||||||
| Operating income | 169 | 204 | (17) | ||||||||
| Other income (expense): | |||||||||||
| Interest expense, bank fees and other | (7) | (5) | 40 | ||||||||
| Interest income | 18 | 1 | 1,700 | ||||||||
| Income before provision for income taxes | 180 | 200 | (10) | ||||||||
| Income taxes | 49 | 54 | (9) | ||||||||
| Net income | $ | 131 | $ | 146 | (10) | % | |||||
| Cash Flow Data: | |||||||||||
| Net cash provided by (used in) operating activities | (77) | 214 | (136) | ||||||||
| Net cash used in investing activities | (23) | (213) | (89) | ||||||||
| Net cash provided by (used in) financing activities | 200 | (353) | (157) | ||||||||
|
Non-GAAP measures
(1)
:
|
|||||||||||
| Adjusted EBITDA | $ | 223 | 242 | (8) | |||||||
| Adjusted Net income | $ | 150 | 168 | (11) | |||||||
| Corporate Operating Cash Flows | 169 | 193 | (12) | ||||||||
| Operating Metrics: | |||||||||||
| Insurance Cost Ratio | 82 | % | 80 | % | 2 | % | |||||
| Average WSEs | 327,107 | 343,245 | (5) | % | |||||||
| Total WSEs | 328,299 | 348,349 | (6) | % | |||||||
|
Average HRIS Users
(2)
|
231,347 | 253,766 | (9) | % | |||||||
| (in millions) |
March 31,
2023 |
December 31,
2022 |
% Change | |||||||||||||||||
| Balance Sheet Data: | ||||||||||||||||||||
| Working capital | 394 | $ | 338 | 17 | % | |||||||||||||||
| Total assets | 3,736 | 3,443 | 9 | |||||||||||||||||
| Debt | 791 | 496 | 59 | |||||||||||||||||
| Total stockholders’ equity | 825 | 775 | 6 | |||||||||||||||||
| TRINET |
10
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| Non-GAAP Measure | Definition |
How We Use The Measure
|
||||||
|
Adjusted EBITDA
|
• Net income, excluding the effects of:
- income tax provision,
- interest expense, bank fees and other,
- depreciation,
- amortization of intangible assets,
- stock based compensation expense,
- amortization of cloud computing arrangements, and
- transaction and integration costs.
|
• Provides period-to-period comparisons on a consistent basis and an understanding as to how our management evaluates the effectiveness of our business strategies by excluding certain non-recurring costs, which include transaction and integration costs, as well as certain non-cash charges such as depreciation and amortization, and stock-based compensation and certain impairment charges recognized based on the estimated fair values. We believe these charges are either not directly resulting from our core operations or not indicative of our ongoing operations.
• Enhances comparisons to the prior period and, accordingly, facilitates the development of future projections and earnings growth prospects. • Provides a measure, among others, used in the determination of incentive compensation for management. • We also sometimes refer to Adjusted EBITDA margin, which is the ratio of Adjusted EBITDA to total revenues. |
||||||
|
Adjusted Net Income
|
• Net income, excluding the effects of:
- effective income tax rate
(1)
,
- stock based compensation,
- amortization of intangible assets, net,
- non-cash interest expense,
- transaction and integration costs, and
- the income tax effect (at our effective tax rate
(1)
of these pre-tax adjustments.
|
• Provides information to our stockholders and board of directors to understand how our management evaluates our business, to monitor and evaluate our operating results, and analyze profitability of our ongoing operations and trends on a consistent basis by excluding certain non-cash charges. | ||||||
| Corporate Operating Cash Flows |
• Net cash provided by (used in) operating activities, excluding the effects of:
- Assets associated with WSEs (accounts receivable, unbilled revenue, prepaid expenses and other current assets) and - Liabilities associated with WSEs (client deposits and other client liabilities, accrued wages, payroll tax liabilities and other payroll withholdings, accrued health benefit costs, accrued workers' compensation costs, insurance premiums and other payables, and other current liabilities). |
• Provides information that our stockholders and management can use to evaluate our cash flows from operations independent of the current assets and liabilities associated with our WSEs.
• Enhances comparisons to prior period and, accordingly, used as a liquidity measure to manage liquidity between corporate and WSE related activities, and to help determine and plan our cash flow and capital strategies.
|
||||||
| TRINET |
11
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| Three Months Ended March 31, | ||||||||
|
(in millions)
|
2023 | 2022 | ||||||
|
Net income
|
$ | 131 | $ | 146 | ||||
|
Provision for income taxes
|
49 | 54 | ||||||
|
Stock based compensation
|
11 | 12 | ||||||
| Interest expense, bank fees and other | 7 | 6 | ||||||
| Depreciation and amortization of intangible assets | 18 | 14 | ||||||
| Amortization of cloud computing arrangements | 2 | — | ||||||
| Transaction and integration costs | 5 | 10 | ||||||
| Adjusted EBITDA | $ | 223 | $ | 242 | ||||
|
Adjusted EBITDA Margin
|
17.9 | % | 19.9 | % | ||||
| Three Months Ended March 31, | ||||||||
|
(in millions)
|
2023 | 2022 | ||||||
|
Net income
|
$ | 131 | $ | 146 | ||||
| Effective income tax rate adjustment | 3 | 4 | ||||||
| Stock based compensation | 11 | 12 | ||||||
| Amortization of other intangible assets, net | 6 | 3 | ||||||
| Transaction and integration costs | 5 | 10 | ||||||
| Income tax impact of pre-tax adjustments | (6) | (7) | ||||||
| Adjusted Net Income | $ | 150 | $ | 168 | ||||
|
Three Months Ended
March 31, |
||||||||
| (in millions) | 2023 | 2022 | ||||||
| Net cash provided by (used in) operating activities | $ | (77) | $ | 214 | ||||
| Less: Change in WSE related other current assets | (178) | (9) | ||||||
| Less: Change in WSE related liabilities | (68) | 30 | ||||||
| Net cash provided by (used in) operating activities - WSE | $ | (246) | $ | 21 | ||||
| Net cash provided by operating activities - Corporate | $ | 169 | $ | 193 | ||||
| TRINET |
12
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| TRINET |
13
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| Three Months Ended March 31, | ||||||||
| (in millions) | 2023 | 2022 | ||||||
| Insurance costs | $ | 852 | $ | 823 | ||||
| Insurance service revenues | 1,041 | 1,024 | ||||||
| Insurance Cost Ratio | 82 | % | 80 | % | ||||
| TRINET |
14
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| PSR |
|
|||||||||||||
| ISR - % represents proportion of insurance service revenues to total revenues | ||||||||||||||
|
*Total revenues generated from PEO services only
|
||||||||||||||
| TRINET |
15
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| (in millions) | |||||||||||
| $204 | First Quarter 2022 Operating Income | ||||||||||
| +28 |
Higher total revenues primarily driven by rate increases and a full quarter of HRIS revenue, partially offset by lower Average WSEs.
|
||||||||||
| -29 | Higher insurance costs primarily as a result of higher medical services utilization and health cost inflation partially offset by lower Average WSEs. | ||||||||||
| -34 | Higher OE primarily as a result of higher compensation expenses to support a full quarter of supporting the HRIS product as well as initiatives to improve client experience, enhance service offerings, and improve processes, together with higher sales and marketing expenses. | ||||||||||
| $169 | First Quarter 2023 Operating Income | ||||||||||
| TRINET |
16
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| Three Months Ended March 31, | ||||||||
| (in millions) | 2023 | 2022 | ||||||
| PEO Services | $ | 193 | $ | 188 | ||||
|
HRIS Cloud Services
|
12 | 6 | ||||||
| Total | $ | 205 | $ | 194 | ||||
| TRINET |
17
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| TRINET |
18
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| % represents portion of compensation related expense included in operating expenses | |||||||||||||||||||||||||||||
| TRINET |
19
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| (in millions) | ||||||||
| $191 | Q1 2022 Operating Expenses | |||||||
| +8 | COPS increased, driven primarily by additional hiring and incremental costs related to a full quarter of our HRIS services product. | |||||||
| +24 |
S&M increased, driven primarily by advertising costs, broker commissions, additional hiring and higher compensation to support sales.
|
|||||||
| -4 | G&A decreased, driven primarily by lower transaction and integration expenses. | |||||||
| +1 | SD&P was consistent with the prior year as we continue to invest in our systems and processes. | |||||||
| +5 |
D&A increased due to the amortization of intangible assets recognized for the Zenefits and Clarus R+D acquisitions.
|
|||||||
| $225 | Q1 2023 Operating Expenses | |||||||
| TRINET |
20
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| TRINET |
21
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| March 31, 2023 | December 31, 2022 | ||||||||||||||||||||||
| (in millions) | Corporate | WSE | Total | Corporate | WSE | Total | |||||||||||||||||
| Current assets: | |||||||||||||||||||||||
| Cash and cash equivalents | $ | 707 | $ | — | $ | 707 | $ | 354 | $ | — | $ | 354 | |||||||||||
| Investments | 89 | — | 89 | 76 | — | 76 | |||||||||||||||||
| Restricted cash, cash equivalents and investments | 21 | 995 | 1,016 | 22 | 1,241 | 1,263 | |||||||||||||||||
| Other current assets | 84 | 733 | 817 | 78 | 555 | 633 | |||||||||||||||||
| Total current assets | $ | 901 | $ | 1,728 | $ | 2,629 | $ | 530 | $ | 1,796 | $ | 2,326 | |||||||||||
| Total current liabilities | $ | 507 | $ | 1,728 | $ | 2,235 | $ | 192 | $ | 1,796 | $ | 1,988 | |||||||||||
| Working capital | $ | 394 | $ | — | $ | 394 | $ | 338 | $ | — | $ | 338 | |||||||||||
| TRINET |
22
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| Three Months Ended March 31, | |||||||||||||||||||||||
| (in millions) | 2023 | 2022 | |||||||||||||||||||||
| Corporate | WSE | Total | Corporate | WSE | Total | ||||||||||||||||||
| Net cash provided by (used in): | |||||||||||||||||||||||
| Operating activities | $ | 169 | $ | (246) | $ | (77) | $ | 193 | $ | 21 | $ | 214 | |||||||||||
| Investing activities | (21) | (2) | (23) | (209) | (4) | (213) | |||||||||||||||||
| Financing activities | 200 | — | 200 | (353) | — | (353) | |||||||||||||||||
| Net increase (decrease) in cash and cash equivalents, unrestricted and restricted | $ | 348 | $ | (248) | $ | 100 | $ | (369) | $ | 17 | $ | (352) | |||||||||||
| Cash and cash equivalents, unrestricted and restricted: | |||||||||||||||||||||||
| Beginning of period | $ | 406 | $ | 1,131 | $ | 1,537 | $ | 660 | $ | 1,078 | $ | 1,738 | |||||||||||
| End of period | $ | 754 | $ | 883 | $ | 1,637 | $ | 291 | $ | 1,095 | $ | 1,386 | |||||||||||
| Net increase (decrease) in cash and cash equivalents: | |||||||||||||||||||||||
| Unrestricted | $ | 353 | $ | — | $ | 353 | $ | (377) | $ | — | $ | (377) | |||||||||||
| Restricted | $ | (5) | $ | (248) | $ | (253) | $ | 8 | $ | 17 | $ | 25 | |||||||||||
| Three Months Ended March 31, | ||||||||
| (in millions) | 2023 | 2022 | ||||||
| Net cash provided by (used in) operating activities | $ | (77) | $ | 214 | ||||
| Net cash provided by (used in) operating activities - WSE | (246) | 21 | ||||||
| Net cash provided by operating activities - Corporate | 169 | 193 | ||||||
| TRINET |
23
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| Three Months Ended March 31, | ||||||||
| (in millions) | 2023 | 2022 | ||||||
| Investments: | ||||||||
| Purchases of investments | $ | (82) | $ | (91) | ||||
| Proceeds from sale and maturity of investments | 76 | 72 | ||||||
| Acquisition of subsidiary | — | (183) | ||||||
| Cash used in investments | $ | (6) | $ | (202) | ||||
| Capital expenditures: | ||||||||
| Software and hardware | $ | (15) | $ | (10) | ||||
| Office furniture, equipment and leasehold improvements | (2) | (1) | ||||||
| Cash used in capital expenditures | $ | (17) | $ | (11) | ||||
| Cash used in investing activities | $ | (23) | $ | (213) | ||||
| TRINET |
24
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| Three Months Ended March 31, | ||||||||
| (in millions) | 2023 | 2022 | ||||||
| Financing activities | ||||||||
| Repurchase of common stock | (95) | (353) | ||||||
| Revolver drawdown, net of repayment | 295 | — | ||||||
| Cash provided by (used in) financing activities | $ | 200 | $ | (353) | ||||
| TRINET |
25
|
2023 Q1 FORM 10-Q | ||||||
| MANAGEMENT'S DISCUSSION AND ANALYSIS | |||||
| TRINET |
26
|
2023 Q1 FORM 10-Q | ||||||
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
AND CONTROLS AND PROCEDURES
|
|||||
| TRINET |
27
|
2023 Q1 FORM 10-Q | ||||||
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
AND CONTROLS AND PROCEDURES
|
|||||
| TRINET |
28
|
2023 Q1 FORM 10-Q | ||||||
| FINANCIAL STATEMENTS | |||||
| Three Months Ended March 31, | ||||||||
| (in millions except per share data) | 2023 | 2022 | ||||||
|
Professional service revenues
|
$ |
|
$ |
|
||||
|
Insurance service revenues
|
|
|
||||||
|
Total revenues
|
|
|
||||||
|
Insurance costs
|
|
|
||||||
|
Cost of providing services
|
|
|
||||||
|
Sales and marketing
|
|
|
||||||
|
General and administrative
|
|
|
||||||
|
Systems development and programming
|
|
|
||||||
|
Depreciation and amortization of intangible assets
|
|
|
||||||
|
Total costs and operating expenses
|
|
|
||||||
|
Operating income
|
|
|
||||||
|
Other income (expense):
|
||||||||
|
Interest expense, bank fees and other
|
(
|
(
|
||||||
|
Interest income
|
|
|
||||||
|
Income before provision for income taxes
|
|
|
||||||
|
Income taxes
|
|
|
||||||
|
Net income
|
$ |
|
$ |
|
||||
| Other comprehensive income (loss), net of income taxes |
|
(
|
||||||
|
Comprehensive income
|
$ |
|
$ |
|
||||
|
Net income per share:
|
||||||||
|
Basic
|
$ |
|
$ |
|
||||
|
Diluted
|
$ |
|
$ |
|
||||
|
Weighted average shares:
|
||||||||
|
Basic
|
|
|
||||||
|
Diluted
|
|
|
||||||
| TRINET |
29
|
2023 Q1 FORM 10-Q | ||||||
| FINANCIAL STATEMENTS | |||||
| March 31, | December 31, | |||||||||||||
| (in millions, except share and per share data) | 2023 | 2022 | ||||||||||||
| ASSETS | ||||||||||||||
| Current assets: | ||||||||||||||
|
Cash and cash equivalents
|
$ |
|
$ |
|
||||||||||
|
Investments
|
|
|
||||||||||||
|
Restricted cash, cash equivalents and investments
|
|
|
||||||||||||
|
Accounts receivable, net
|
|
|
||||||||||||
|
Unbilled revenue, net
|
|
|
||||||||||||
|
Prepaid expenses, net
|
|
|
||||||||||||
| Other payroll assets |
|
|
||||||||||||
|
Other current assets
|
|
|
||||||||||||
| Total current assets |
|
|
||||||||||||
|
Restricted cash, cash equivalents and investments, noncurrent
|
|
|
||||||||||||
|
Investments, noncurrent
|
|
|
||||||||||||
| Property and equipment, net |
|
|
||||||||||||
|
Operating lease right-of-use asset
|
|
|
||||||||||||
|
Goodwill
|
|
|
||||||||||||
| Software and other intangible assets, net |
|
|
||||||||||||
|
Other assets
|
|
|
||||||||||||
| Total assets | $ |
|
$ |
|
||||||||||
| Liabilities and stockholders' equity | ||||||||||||||
| Current liabilities: | ||||||||||||||
|
Accounts payable and other current liabilities
|
$ |
|
$ |
|
||||||||||
|
Revolving credit agreement borrowings
|
|
|
||||||||||||
|
Client deposits and other client liabilities
|
|
|
||||||||||||
|
Accrued wages
|
|
|
||||||||||||
|
Accrued health insurance costs, net
|
|
|
||||||||||||
|
Accrued workers' compensation costs, net
|
|
|
||||||||||||
|
Payroll tax liabilities and other payroll withholdings
|
|
|
||||||||||||
|
Operating lease liabilities
|
|
|
||||||||||||
|
Insurance premiums and other payables
|
|
|
||||||||||||
| Total current liabilities |
|
|
||||||||||||
|
Long-term debt, noncurrent
|
|
|
||||||||||||
|
Accrued workers' compensation costs, noncurrent, net
|
|
|
||||||||||||
|
Deferred taxes
|
|
|
||||||||||||
|
Operating lease liabilities, noncurrent
|
|
|
||||||||||||
|
Other non-current liabilities
|
|
|
||||||||||||
| Total liabilities |
|
|
||||||||||||
|
|
|
|||||||||||||
| Stockholders' equity: | ||||||||||||||
| Preferred stock |
|
|
||||||||||||
|
($
|
||||||||||||||
| Common stock and additional paid-in capital |
|
|
||||||||||||
|
($
|
||||||||||||||
| Retained earnings (Accumulated deficit) |
(
|
(
|
||||||||||||
| Accumulated other comprehensive loss |
(
|
(
|
||||||||||||
| Total stockholders' equity |
|
|
||||||||||||
| Total liabilities & stockholders' equity | $ |
|
$ |
|
||||||||||
| TRINET |
30
|
2023 Q1 FORM 10-Q | ||||||
| FINANCIAL STATEMENTS | |||||
| Three Months Ended March 31, | ||||||||
|
(in millions)
|
2023 | 2022 | ||||||
| Total Stockholders' Equity, beginning balance | $ |
|
$ |
|
||||
| Common Stock and Additional Paid-In Capital | ||||||||
|
Beginning balance
|
|
|
||||||
| Issuance of common stock for the acquisition of Zenefits |
|
|
||||||
|
Stock based compensation expense
|
|
|
||||||
|
Ending balance
|
|
|
||||||
| Retained Earnings (Accumulated Deficit) | ||||||||
|
Beginning balance
|
(
|
|
||||||
|
Net income
|
|
|
||||||
|
Repurchase of common stock
|
(
|
(
|
||||||
|
Awards effectively repurchased for required employee withholding taxes
|
(
|
(
|
||||||
|
Ending balance
|
(
|
(
|
||||||
| Accumulated Other Comprehensive Income | ||||||||
|
Beginning balance
|
(
|
(
|
||||||
| Other comprehensive income (loss) |
|
(
|
||||||
|
Ending balance
|
(
|
(
|
||||||
|
Total Stockholders' Equity, ending balance
|
$ |
|
$ |
|
||||
| TRINET |
31
|
2023 Q1 FORM 10-Q | ||||||
| FINANCIAL STATEMENTS | |||||
| Three Months Ended March 31, | ||||||||
| (in millions) | 2023 | 2022 | ||||||
|
Operating activities
|
||||||||
|
Net income
|
$ |
|
$ |
|
||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
|
Depreciation and amortization
|
|
|
||||||
| Amortization of ROU asset, lease modification, impairment, and abandonment |
|
|
||||||
| Stock based compensation |
|
|
||||||
|
Deferred income taxes
|
|
|
||||||
|
Provision for doubtful accounts
|
|
|
||||||
| Other |
|
|
||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable, net
|
|
|
||||||
| Unbilled revenue, net |
|
|
||||||
| Other assets and prepaid expenses, net |
(
|
|
||||||
| Other payroll assets |
(
|
(
|
||||||
| Accounts payable and other liabilities |
|
|
||||||
| Client deposits and other client liabilities |
|
|
||||||
| Accrued wages |
(
|
|
||||||
| Accrued health insurance costs, net |
(
|
(
|
||||||
| Accrued workers' compensation costs, net |
(
|
|
||||||
| Payroll taxes payable and other payroll withholdings |
(
|
(
|
||||||
| Operating lease liabilities |
(
|
(
|
||||||
| Net cash provided by (used in) operating activities |
(
|
|
||||||
|
Investing activities
|
||||||||
|
Purchases of marketable securities
|
(
|
(
|
||||||
| Proceeds from sale and maturity of marketable securities |
|
|
||||||
| Acquisitions of property and equipment |
(
|
(
|
||||||
| Acquisition of subsidiary, net of cash acquired |
|
(
|
||||||
|
Net cash used in investing activities
|
(
|
(
|
||||||
|
Financing activities
|
||||||||
|
Repurchase of common stock
|
(
|
(
|
||||||
| Revolver drawdown |
|
|
||||||
| Revolver repayment |
(
|
|
||||||
|
Awards effectively repurchased for required employee withholding taxes
|
(
|
(
|
||||||
| Net cash provided by (used in) financing activities |
|
(
|
||||||
| Net increase (decrease) in cash and cash equivalents, unrestricted and restricted |
|
(
|
||||||
|
Cash and cash equivalents, unrestricted and restricted:
|
||||||||
|
Beginning of period
|
|
|
||||||
|
End of period
|
$ |
|
$ |
|
||||
|
Supplemental disclosures of cash flow information
|
||||||||
|
Interest paid
|
$ |
|
$ |
|
||||
| Income taxes (refund) paid, net | $ |
|
$ |
(
|
||||
|
Supplemental schedule of noncash investing and financing activities
|
||||||||
| Payable for purchase of property and equipment | $ |
|
$ |
|
||||
| TRINET |
32
|
2023 Q1 FORM 10-Q | ||||||
| FINANCIAL STATEMENTS | |||||
| TRINET |
33
|
2023 Q1 FORM 10-Q | ||||||
| FINANCIAL STATEMENTS | |||||
| March 31, 2023 | March 31, 2022 | |||||||
| (in millions) | Three Months Ended | Three Months Ended | ||||||
| Balance at beginning of period | $ |
|
$ |
|
||||
| (-) Distributions to clients |
(
|
(
|
||||||
| Balance at end of period | $ |
|
$ |
|
||||
| TRINET |
34
|
2023 Q1 FORM 10-Q | ||||||
| FINANCIAL STATEMENTS | |||||
| TRINET |
35
|
2023 Q1 FORM 10-Q | ||||||
| FINANCIAL STATEMENTS | |||||
| March 31, 2023 | December 31, 2022 | ||||||||||||||||||||||||||||
| (in millions) | Cash and cash equivalents | Available-for-sale marketable securities | Total | Cash and cash equivalents | Available-for-sale marketable securities | Total | |||||||||||||||||||||||
| Cash and cash equivalents | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||
| Investments |
|
|
|
|
|
|
|||||||||||||||||||||||
| Restricted cash, cash equivalents and investments: | |||||||||||||||||||||||||||||
| Payroll funds collected |
|
|
|
|
|
|
|||||||||||||||||||||||
| Collateral for health benefits claims |
|
|
|
|
|
|
|||||||||||||||||||||||
| Collateral for workers' compensation claims |
|
|
|
|
|
|
|||||||||||||||||||||||
| Other security deposits |
|
|
|
|
|
|
|||||||||||||||||||||||
| Total restricted cash, cash equivalents and investments |
|
|
|
|
|
|
|||||||||||||||||||||||
| Investments, noncurrent |
|
|
|
|
|
|
|||||||||||||||||||||||
| Restricted cash, cash equivalents and investments, noncurrent | |||||||||||||||||||||||||||||
| Collateral for workers' compensation claims |
|
|
|
|
|
|
|||||||||||||||||||||||
| Other security deposits |
|
|
|
|
|
|
|||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||
| TRINET |
36
|
2023 Q1 FORM 10-Q | ||||||
| FINANCIAL STATEMENTS | |||||
| (in millions) | Fair Value Level | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Cash and Cash Equivalents | Investments | Restricted Cash, Cash Equivalents and Investments | ||||||||||||||||||
| March 31, 2023 | ||||||||||||||||||||||||||
| Cash equivalents: | ||||||||||||||||||||||||||
| Money market mutual funds | Level 1 | $ |
|
$ | — | $ | — | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||
| U.S. treasuries | Level 2 |
|
— | — |
|
|
|
|
||||||||||||||||||
| Total cash equivalents |
|
— | — |
|
|
|
|
|||||||||||||||||||
| AFS Investments: | ||||||||||||||||||||||||||
| Asset-backed securities | Level 2 |
|
|
(
|
|
|
|
|
||||||||||||||||||
| Corporate bonds | Level 2 |
|
|
(
|
|
|
|
|
||||||||||||||||||
| Agency securities | Level 2 |
|
|
(
|
|
|
|
|
||||||||||||||||||
| U.S. treasuries | Level 2 |
|
|
|
|
|
|
|
||||||||||||||||||
| Certificate of deposit | Level 2 |
|
|
|
|
|
|
|
||||||||||||||||||
| Other debt securities | Level 2 |
|
|
|
|
|
|
|
||||||||||||||||||
| Total AFS Investments | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||
| (in millions) | Fair Value Level | Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | Cash and Cash Equivalents | Investments | Restricted Cash, Cash Equivalents and Investments | ||||||||||||||||||
| December 31, 2022 | ||||||||||||||||||||||||||
| Cash equivalents: | ||||||||||||||||||||||||||
| Money market mutual funds | Level 1 | $ |
|
$ | — | $ | — | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||
| U.S. treasuries | Level 2 |
|
— | — |
|
|
|
|
||||||||||||||||||
| Total cash equivalents |
|
— | — |
|
|
|
|
|||||||||||||||||||
| AFS Investments: | ||||||||||||||||||||||||||
| Asset-backed securities | Level 2 |
|
|
(
|
|
|
|
|
||||||||||||||||||
| Corporate bonds | Level 2 |
|
|
(
|
|
|
|
|
||||||||||||||||||
| Agency securities | Level 2 |
|
|
(
|
|
|
|
|
||||||||||||||||||
| U.S. treasuries | Level 2 |
|
|
|
|
|
|
|
||||||||||||||||||
| Certificate of deposit | Level 2 |
|
|
|
|
|
|
|
||||||||||||||||||
| Other debt securities | Level 2 |
|
|
|
|
|
|
|
||||||||||||||||||
| Total AFS Investments | $ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||
| TRINET |
37
|
2023 Q1 FORM 10-Q | ||||||
| FINANCIAL STATEMENTS | |||||
| (in millions) | March 31, 2023 | ||||||||||
| One year or less | $ |
|
|||||||||
| Over one year through five years |
|
||||||||||
| Over five years through ten years |
|
||||||||||
| Over ten years |
|
||||||||||
| Total fair value | $ |
|
|||||||||
| Three Months Ended March 31, | ||||||||
| (in millions) | 2023 | 2022 | ||||||
| Gross proceeds from sales | $ |
|
$ |
|
||||
| Gross proceeds from maturities |
|
|
||||||
| Total | $ |
|
$ |
|
||||
| TRINET |
38
|
2023 Q1 FORM 10-Q | ||||||
| FINANCIAL STATEMENTS | |||||
|
Three Months Ended
March 31, |
||||||||
| (in millions) | 2023 | 2022 | ||||||
| Total accrued costs, beginning of period | $ |
|
$ |
|
||||
| Incurred | ||||||||
| Current year |
|
|
||||||
| Prior years |
(
|
(
|
||||||
| Total incurred |
|
|
||||||
| Paid | ||||||||
| Current year |
(
|
|
||||||
| Prior years |
(
|
(
|
||||||
| Total paid |
(
|
(
|
||||||
| Total accrued costs, end of period | $ |
|
$ |
|
||||
| (in millions) | March 31, 2023 | December 31, 2022 | ||||||
| Total accrued costs, end of period | $ |
|
$ |
|
||||
| Collateral paid to carriers and offset against accrued costs |
(
|
(
|
||||||
| Total accrued costs, net of carrier collateral offset | $ |
|
$ |
|
||||
|
Payable in less than 1 year
(net of collateral paid to carriers of $ |
$ |
|
$ |
|
||||
|
Payable in more than 1 year
(net of collateral paid to carriers of $ |
|
|
||||||
| Total accrued costs, net of carrier collateral offset | $ |
|
$ |
|
||||
| TRINET |
39
|
2023 Q1 FORM 10-Q | ||||||
| FINANCIAL STATEMENTS | |||||
| TRINET |
40
|
2023 Q1 FORM 10-Q | ||||||
| FINANCIAL STATEMENTS | |||||
|
Total Number
of RSUs
|
Total Number
of Shares
|
Weighted-Average
Grant Date
Fair Value
|
||||||||||||
| Nonvested at December 31, 2022 |
|
|
$ |
|
||||||||||
| Granted |
|
|
|
|||||||||||
| Vested |
(
|
(
|
|
|||||||||||
| Forfeited |
(
|
(
|
|
|||||||||||
| Nonvested at March 31, 2023 |
|
|
$ |
|
||||||||||
|
Total Number
of RSUs
|
Total Number of Shares |
Weighted-Average
Grant Date
Fair Value
|
||||||||||||
| Nonvested at December 31, 2022 |
|
|
$ |
|
||||||||||
| Granted |
|
|
|
|||||||||||
| Nonvested at March 31, 2023 |
|
|
$ |
|
||||||||||
| Three Months Ended March 31, | ||||||||
| (in millions) | 2023 | 2022 | ||||||
| Cost of providing services | $ |
|
$ |
|
||||
| Sales and marketing |
|
|
||||||
| General and administrative |
|
|
||||||
| Systems development and programming costs |
|
|
||||||
| Total stock based compensation expense | $ |
|
$ |
|
||||
| Total stock based compensation capitalized | $ |
|
$ |
|
||||
| TRINET |
41
|
2023 Q1 FORM 10-Q | ||||||
| FINANCIAL STATEMENTS | |||||
|
Three Months Ended
March 31, |
||||||||
| 2023 | 2022 | |||||||
| Shares issued and outstanding, beginning balance |
|
|
||||||
|
Issuance of common stock from vested restricted stock units
|
|
|
||||||
|
Issuance of common stock from exercise of stock options
|
|
|
||||||
|
Issuance of common stock for the acquisition of Zenefits
|
|
|
||||||
|
Repurchase of common stock
|
(
|
(
|
||||||
|
Awards effectively repurchased for required employee withholding taxes
|
(
|
(
|
||||||
|
Shares issued and outstanding, ending balance
|
|
|
||||||
|
Three Months Ended
March 31, |
||||||||
| (in millions, except per share data) | 2023 | 2022 | ||||||
| Net income | $ |
|
$ |
|
||||
| Weighted average shares of common stock outstanding |
|
|
||||||
| Basic EPS | $ |
|
$ |
|
||||
| Net income | $ |
|
$ |
|
||||
| Weighted average shares of common stock outstanding |
|
|
||||||
| Dilutive effect of stock options and restricted stock units |
|
|
||||||
| Weighted average shares of common stock outstanding |
|
|
||||||
| Diluted EPS | $ |
|
$ |
|
||||
|
Common stock equivalents excluded from income per diluted share because of their anti-dilutive effect
|
|
|
||||||
| TRINET |
42
|
2023 Q1 FORM 10-Q | ||||||
| OTHER INFORMATION | |||||
| Period |
Total Number of
Shares
Purchased
(1) (2)
|
Weighted Average Price
Paid Per Share |
Total Number of
Shares Purchased as Part of Publicly Announced Plans |
Approximate Dollar Value ($ millions)
of Shares that May Yet be Purchased Under the Plans (3) |
|||||||||||||||||||||||||
| January 1 - January 31, 2023 | 458,106 | $ | 73.56 | 456,099 | $ | 211 | |||||||||||||||||||||||
| February 1 - February 28, 2023 | 407,750 | $ | 80.52 | 360,425 | $ | 482 | |||||||||||||||||||||||
| March 1 - March 31, 2023 | 341,716 | $ | 80.12 | 341,347 | $ | 455 | |||||||||||||||||||||||
| Total | 1,207,572 | 1,157,871 | |||||||||||||||||||||||||||
| TRINET |
43
|
2023 Q1 FORM 10-Q | ||||||
| EXHIBITS | |||||
| Incorporated by Reference | ||||||||||||||||||||||||||||||||||||||
| Exhibit No. | Exhibit | Form | File No. | Exhibit | Filing Date | Filed Herewith | ||||||||||||||||||||||||||||||||
| 3.1 | 8-K | 001-36373 | 3.1 | 4/1/2014 | ||||||||||||||||||||||||||||||||||
| 3.2 | 10-Q | 001-36373 | 3.1 | 11/2/2017 | ||||||||||||||||||||||||||||||||||
| 3.3 | 8-K | 001-36373 | 3.1 | 3/27/2023 | ||||||||||||||||||||||||||||||||||
| 4.1 | 8-K | 001-36373 | 4.1 | 2/2/2017 | ||||||||||||||||||||||||||||||||||
| 10.1 | 10-K | 001-36373 | 10.22 | 2/15/2023 | ||||||||||||||||||||||||||||||||||
| 31.1 | X | |||||||||||||||||||||||||||||||||||||
| 31.2 | X | |||||||||||||||||||||||||||||||||||||
|
32.1*
|
X | |||||||||||||||||||||||||||||||||||||
|
101.INS
|
XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document
|
|||||||||||||||||||||||||||||||||||||
|
101.SCH
|
XBRL Taxonomy Extension Schema Linkbase Document
|
|||||||||||||||||||||||||||||||||||||
|
101.CAL
|
XBRL Taxonomy Extension Calculation Linkbase Document
|
|||||||||||||||||||||||||||||||||||||
|
101.DEF
|
XBRL Taxonomy Extension Definition Linkbase Document
|
|||||||||||||||||||||||||||||||||||||
|
101.LAB
|
XBRL Taxonomy Extension Label Linkbase Document
|
|||||||||||||||||||||||||||||||||||||
|
101.PRE
|
XBRL Taxonomy Extension Presentation Linkbase Document
|
|||||||||||||||||||||||||||||||||||||
| 104 | Cover Page Interactive Data File (embedded with the Inline XBRL document) | |||||||||||||||||||||||||||||||||||||
| * | Document has been furnished, is deemed not filed and is not to be incorporated by reference into any of TriNet Group, Inc.’s filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, irrespective of any general incorporation language contained in any such filing. | |||||||
| TRINET |
44
|
2023 Q1 FORM 10-Q | ||||||
| SIGNATURES | |||||
| TRINET GROUP, INC. | |||||||||||
| Date: April 26, 2023 | By: | /s/ Burton M. Goldfield | |||||||||
| Burton M. Goldfield | |||||||||||
| Chief Executive Officer | |||||||||||
| Date: April 26, 2023 | By: | /s/ Kelly Tuminelli | |||||||||
| Kelly Tuminelli | |||||||||||
| Chief Financial Officer | |||||||||||
| TRINET |
45
|
2023 Q1 FORM 10-Q | ||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|